Your browser doesn't support javascript.
loading
Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases.
Zerr, Inga; Schmitz, Matthias; Karch, André; Villar-Piqué, Anna; Kanata, Eirini; Golanska, Ewa; Díaz-Lucena, Daniela; Karsanidou, Aikaterini; Hermann, Peter; Knipper, Tobias; Goebel, Stefan; Varges, Daniela; Sklaviadis, Theodoros; Sikorska, Beata; Liberski, Pawel P; Santana, Isabel; Ferrer, Isidro; Zetterberg, Henrik; Blennow, Kaj; Calero, Olga; Calero, Miguel; Ladogana, Anna; Sánchez-Valle, Raquel; Baldeiras, Inês; Llorens, Franc.
Affiliation
  • Zerr I; Department of Neurology, University Medical School, Göttingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
  • Schmitz M; Department of Neurology, University Medical School, Göttingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
  • Karch A; Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Villar-Piqué A; Department of Neurology, University Medical School, Göttingen, Germany.
  • Kanata E; Laboratory of Pharmacology, School of Health Sciences, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Golanska E; Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland.
  • Díaz-Lucena D; Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain.
  • Karsanidou A; Laboratory of Pharmacology, School of Health Sciences, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Hermann P; Department of Neurology, University Medical School, Göttingen, Germany.
  • Knipper T; Department of Neurology, University Medical School, Göttingen, Germany.
  • Goebel S; Department of Neurology, University Medical School, Göttingen, Germany.
  • Varges D; Department of Neurology, University Medical School, Göttingen, Germany.
  • Sklaviadis T; Laboratory of Pharmacology, School of Health Sciences, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Sikorska B; Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland.
  • Liberski PP; Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland.
  • Santana I; Neurology Department, CHUC-Centro Hospitalar e Universitário de Coimbra, CNC- Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Ferrer I; Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain; Senior Consultant, Bellvitge University Hospital-IDIBELL, Department of Pathology and Experimental Therapeutics, University of Barcel
  • Zetterberg H; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute o
  • Blennow K; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
  • Calero O; Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain; Alzheimer Disease Research Unit, CIEN Foundation; Queen Sofia Foundation Alzheimer Center; Chronic Disease Programme Carlos III Insti
  • Calero M; Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain; Alzheimer Disease Research Unit, CIEN Foundation; Queen Sofia Foundation Alzheimer Center; Chronic Disease Programme Carlos III Insti
  • Ladogana A; Department of Neurosciences, Istituto Superiore di Sanità, Rome, Italy.
  • Sánchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Department, Hospital Clínic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Baldeiras I; Neurology Department, CHUC-Centro Hospitalar e Universitário de Coimbra, CNC- Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Llorens F; Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain. Electronic address: franc.llorens@gmail.com.
Alzheimers Dement ; 14(6): 751-763, 2018 06.
Article in En | MEDLINE | ID: mdl-29391125
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tau Proteins / Prion Diseases / Dementia Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Alzheimers Dement Year: 2018 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tau Proteins / Prion Diseases / Dementia Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Alzheimers Dement Year: 2018 Type: Article Affiliation country: Germany